ECM
EMC Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Sell |
7,677
-7,084
| -48% | -$154K | 0.09% | 107 |
|
|
2025
Q1 | $358K | Hold |
14,761
| – | – | 0.22% | 65 |
|
|
2024
Q4 | $308K | Buy |
14,761
+12,340
| +510% | +$257K | 0.17% | 92 |
|
|
2024
Q3 | $103K | Sell |
2,421
-12,340
| -84% | -$525K | 0.07% | 227 |
|
|
2024
Q2 | $229K | Hold |
14,761
| – | – | 0.13% | 131 |
|
|
2024
Q1 | $235K | Sell |
14,761
-13,722
| -48% | -$218K | 0.14% | 142 |
|
|
2023
Q4 | $479K | Hold |
28,483
| – | – | 0.32% | 33 |
|
|
2023
Q3 | $333K | Hold |
28,483
| – | – | 0.24% | 58 |
|
|
2023
Q2 | $383 | Hold |
28,483
| – | – | 0.3% | 43 |
|
|
2023
Q1 | $472K | Hold |
28,483
| – | – | 0.4% | 23 |
|
|
2022
Q4 | $530K | Hold |
28,483
| – | – | 0.48% | 14 |
|
|
2022
Q3 | $365K | Hold |
28,483
| – | – | 0.34% | 27 |
|
|
2022
Q2 | $200K | Sell |
28,483
-21,660
| -43% | -$152K | 0.17% | 109 |
|
|
2022
Q1 | $382K | Buy |
+50,143
| New | +$382K | 0.27% | 42 |
|